Design Therapeutics Stock Forecast

Sell candidate since May 29, 2026 Gain 1.62%

The Design Therapeutics, Inc. stock price fell by -1.02% on the last day (Friday, 5th Jun 2026) from $10.76 to $10.65. During the last trading day the stock fluctuated 3.90% from a day low at $10.51 to a day high of $10.92. The price has fallen in 7 of the last 10 days and is down by -3.27% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -383 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $10.25 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 12.09% during the next 3 months and, with a 90% probability hold a price between $11.50 and $18.52 at the end of this 3-month period.

DSGN Signals & Forecast

There are mixed signals in the stock today. The Design Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $12.64. On a fall, the stock will find some support from the short-term average at $10.53. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -1.02%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Design Therapeutics, Inc. stock

Design Therapeutics, Inc. finds support from accumulated volume at $10.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.410 between high and low, or 3.90%. For the last week the stock has had daily average volatility of 4.88%

Design Therapeutics, Inc. is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DSGN) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Design Therapeutics, Inc. to open at $10.69, and during the day (based on 14 day Average True Range), to move between $10.19 and $11.11, which gives a possible trading interval of +/-$0.92 (+/-8.98%) up or down from last closing price. If Design Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $10.70 (0.47%) than the support at $10.49 (1.50%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Design Therapeutics, Inc. stock A Buy?

Design Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.938 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $10.69 ( 0.407%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk